The Library
High-throughput crystallography reveals boron-containing inhibitors of a Penicillin-binding protein with di- and tricovalent binding modes
Tools
Newman, Hector, Krajnc, Alen, Bellini, Dom, Eyermann, Charles J., Boyle, Grant A., Paterson, Neil G., McAuley, Katherine E., Lesniak, Robert, Gangar, Mukesh, von Delft, Frank, Brem, Jürgen, Chibale, Kelly, Schofield, Christopher J. and Dowson, Christopher G. (2021) High-throughput crystallography reveals boron-containing inhibitors of a Penicillin-binding protein with di- and tricovalent binding modes. Journal of Medicinal Chemistry, 64 (15). pp. 11379-11394. doi:10.1021/acs.jmedchem.1c00717 ISSN 0022-2623.
|
PDF
WRAP-crystallography-boron-inhibitors-penicillin-binding-protein-di-tricovalent-Dowson-2021.pdf - Published Version - Requires a PDF viewer. Available under License Creative Commons Attribution 4.0. Download (7Mb) | Preview |
|
|
PDF
WRAP-crystallography-boron-inhibitors-penicillin-binding-protein-di-tricovalent-supporting-information-Dowson-2021.pdf - Supplemental Material - Requires a PDF viewer. Download (3248Kb) | Preview |
Official URL: https://doi.org/10.1021/acs.jmedchem.1c00717
Abstract
The effectiveness of β-lactam antibiotics is increasingly compromised by β-lactamases. Boron-containing inhibitors are potent serine-β-lactamase inhibitors, but the interactions of boron-based compounds with the penicillin-binding protein (PBP) β-lactam targets have not been extensively studied. We used high-throughput X-ray crystallography to explore reactions of a boron-containing fragment set with the PBP3 (PaPBP3). Multiple crystal structures reveal that boronic acids react with PBPs to give tricovalently linked complexes bonded to Ser294, Ser349, and Lys484 of PaPBP3; benzoxaboroles react with PaPBP3 via reaction with two nucleophilic serines (Ser294 and Ser349) to give dicovalently linked complexes; and vaborbactam reacts to give a monocovalently linked complex. Modifications of the benzoxaborole scaffold resulted in a moderately potent inhibition of PaPBP3, though no antibacterial activity was observed. Overall, the results further evidence the potential for the development of new classes of boron-based antibiotics, which are not compromised by β-lactamase-driven resistance.
Item Type: | Journal Article | |||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Subjects: | Q Science > QD Chemistry Q Science > QP Physiology R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica |
|||||||||||||||||||||||||||||||||||||||
Divisions: | Faculty of Science, Engineering and Medicine > Science > Life Sciences (2010- ) | |||||||||||||||||||||||||||||||||||||||
SWORD Depositor: | Library Publications Router | |||||||||||||||||||||||||||||||||||||||
Library of Congress Subject Headings (LCSH): | Beta lactam antibiotics , Beta lactam antibiotics -- Structure-activity relationships , Beta lactam antibiotics -- Synthesis, Beta lactamases, Beta lactamases -- Inhibitors , Protein binding, Boron -- Inhibitors, X-ray crystallography | |||||||||||||||||||||||||||||||||||||||
Journal or Publication Title: | Journal of Medicinal Chemistry | |||||||||||||||||||||||||||||||||||||||
Publisher: | American Chemical Society | |||||||||||||||||||||||||||||||||||||||
ISSN: | 0022-2623 | |||||||||||||||||||||||||||||||||||||||
Official Date: | 12 August 2021 | |||||||||||||||||||||||||||||||||||||||
Dates: |
|
|||||||||||||||||||||||||||||||||||||||
Volume: | 64 | |||||||||||||||||||||||||||||||||||||||
Number: | 15 | |||||||||||||||||||||||||||||||||||||||
Page Range: | pp. 11379-11394 | |||||||||||||||||||||||||||||||||||||||
DOI: | 10.1021/acs.jmedchem.1c00717 | |||||||||||||||||||||||||||||||||||||||
Status: | Peer Reviewed | |||||||||||||||||||||||||||||||||||||||
Publication Status: | Published | |||||||||||||||||||||||||||||||||||||||
Access rights to Published version: | Open Access (Creative Commons) | |||||||||||||||||||||||||||||||||||||||
Date of first compliant deposit: | 6 September 2021 | |||||||||||||||||||||||||||||||||||||||
Date of first compliant Open Access: | 6 September 2021 | |||||||||||||||||||||||||||||||||||||||
RIOXX Funder/Project Grant: |
|
|||||||||||||||||||||||||||||||||||||||
Related URLs: |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |
Downloads
Downloads per month over past year